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ABSTRACT 
SNOMED CT terminology is not backed by standard norms of encoding among pathologists. The 
vast number of concepts ordered in hierarchies and axes, together with the lack of rules of use, 
complicates the functionality of SNOMED CT for coding, extracting, and analyzing the data. 
Defining subgroups of SNOMED CT by discipline could increase its functionality. The challenge 
lies in how to choose the concepts to be included in a subset from a total of over 300,000. 
Besides, SNOMED CT does not cover daily need, as the clinical reality is dynamic and changing. 
To adapt SNOMED CT to needs in a flexible way, the possibility exists to create extensions. 
In Catalonia, most pathology departments have been migrating from SNOMED II to SNOMED CT 
in a bid to advance the development of the Catalan Pathology Registry, which was created in 
2014 as a repository for all the pathological diagnoses. This article explains the methodology 
used to: (a) identify the clinico-pathological entities and the molecular diagnostic procedures 
not included in SNOMED CT; (b) define the theoretical subset and microglossary of pathology; 
(c) describe the SNOMED CT concepts used by pathologists of 1.17 million samples of the 
Catalan Pathology Registry; and d) adapt the theoretical subset and the microglossary according 
to the actual use of SNOMED CT. 
Of the 328,365 concepts available for coding the diagnoses (326,732 in SNOMED CT and 1,576 in 
Catalan extension), only 2% have been used. Combining two axes of SNOMED CT, body structure 
and clinical findings, has enabled coding most of the morphologies. 
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1. Introduction 
 
Population-based cancer registries (PBCRs) are essential for evaluating and monitoring 
the burden of cancer in a country [1-4]. Methodologically, PBCRs have been an 
exemplary model for integrating and linking health data since, according to international 
regulations, they systematically collect information on all newly diagnosed cancers in an 
area from multiple sources of information [5]. The basic sources of data for PBCRs are 
diagnoses of malignancy and hospital discharges, as recorded in pathology laboratories 
and death registries. For tumors, data include the date of diagnosis; tumor site, 
morphology and behavior; diagnostic method; and—if PBCR resources allow—tumor 
stage [5,6]. Government involvement is indispensable to implementing a PBCR in order 
to ensure access to information sources with security protocols that cover patient 
confidentiality and use of personal data [7]. 
Since the advent of information technology improvements in the health sector, PBCRs in 
most developed countries have provided centralized, structured, and standardized 
information according to international standards for diagnoses, hospital discharges, and 
death certificates [8,9]. On the other hand, anatomical pathology diagnoses, generally 
coded with the Systematized Nomenclature of Medicine II (SNOMED II) terminology, 
have been available only locally in each laboratory. Recently, several laboratories have 
begun migrating to SNOMED CT (SNOMED Clinical Terms) [10,11], but the scope and 
complexity of this terminology, together with the lack of a specific and consensus-based 
international subset for pathology, hinders the transition and the normalization of 
SNOMED CT’s use [12,13]. Another disadvantage of SNOMED CT is that pathological 
diagnoses are increasingly based on genetic and molecular procedures, and some of 
these concepts have not yet been transferred to SNOMED CT [14]. Even so, in some 
countries, the migration to SNOMED CT has allowed the unification of diagnoses from 
different pathology laboratories into a single database. The methodology used to 
compile the diagnoses differs and may involve the processing of the natural language of 
electronic pathology records (EPR); direct classification from the SNOMED CT codes 
generated in each pathology department; or both [15-18]. What is obvious is that 
centralizing pathological diagnoses has positive implications both for public health and 
for PBCRs [19]. 
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Catalonia, located in northeastern Spain, with a population of 7.5 million inhabitants, 
has individualized and nominal, centralized and structured information on hospital 
discharges (since 2003) and deaths (since 1985) [20,21]. However, structured and 
centralized data for anatomical pathology are not available. Since 2012, most pathology 
departments have been migrating from SNOMED II to SNOMED CT in a bid to create a 
repository for all the pathological diagnoses in the public healthcare system in Catalonia.  
This article explains the methodology used in Catalonia to: (a) identify the clinico-
pathological entities as well as the genetic and molecular diagnostic procedures not 
included in the SNOMED CT terminology; (b) define a pathology subset and 
microglossary; (c) analyze and describe the SNOMED CT concepts used by pathologists 
to code the topography and diagnoses of 1.17 million samples collected between 
January 1, 2015 and May 31, 2017; and d) validate and adapt the subset and the 
microglossary created according to the actual use that the centers make of SNOMED CT. 
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2. Material and Methods 
SNOMED CT is a clinical terminology owned and maintained by SNOMED International 
(called International Health Terminology Standards Development Organisation; IHTSDO 
until 2016). SNOMED CT covers a broad range of health-related topics with 
comprehensive, scalable, flexible, and internationally controlled vocabulary. The January 
2017 international release had 326,732 active concepts, with 1,111,820 descriptions and 
994,548 relationships [22]. SNOMED CT concepts are the smallest unit of meaning and 
have at least two descriptions: a fully specified name and at least one synonym (with no 
maximum limit). Relationships are links between concept pairs and can express 
hierarchy or define connections. SNOMED CT concepts are organized through a branch-
based structure, where each concept is more specific than its parent; the structure has 
19 different axes: clinical finding, procedure, pharmaceutical/biologic product, 
substance, observable entity, specimen, staging and scales, body structure, 
environment, event, organism, physical force, physical object, qualifier value, record 
artefact, situation with explicit context, metadata, social context, and special concept. 
Each concept belongs to a single axis but can be linked to concepts from others. All 
components in SNOMED CT have a unique numeric identifier, called the ConceptID (for 
concepts), DescriptionID (in the case of descriptions) and RelationshipID (for 
relationships). Concepts also have an association with their corresponding SnomedID 
code. Another important characteristic of SNOMED CT is that it allows the creation of 
subsets to minimize the impact of its adoptions. These subsets are groups of concepts, 
descriptions, or relationships that have been selected for a particular purpose [23].  
The Catalan SNOMED CT Commission decided that a subset of concepts specific to 
pathology was required, since SNOMED CT covers many other specialities. To help make 
diagnostic coding easier and faster, it was decided to create a microglossary that would 
include the smallest possible number of concepts of the subset capable of coding most 
pathology reports. This led to the definition of three levels of pathology dictionaries to 
be installed in the computer applications of the pathology laboratories: microglossary, 
subset and SNOMED CT. This study shows the methodology for creating and validating 
the pathology subset and microglossary. 
2.1. Definition of the pathology subset and microglossary from the College of 
American Pathologists (CAP) subset 
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In 2006, the Catalan Cancer Plan (CCP) acquired the license to use the pathology subset 
of the CAP, which included 71,952 concepts with 190,553 descriptions. In adapting this 
list for use in Catalonia, the first phase consisted of excluding inactive concepts and 
concepts that were not specific to pathology, such as terms related to veterinary 
medicine, mental illness, embryology, behavior, drugs, diagnostic protocols, generic 
qualifiers, immunology and highly specific and difficult-to-access topographies for 
obtaining biological samples. Thirty-eight pathologists from 17 hospitals in Catalonia 
reviewed the subset with the objective of agreeing on a microglossary of no more than 
6,000 priority concepts capable of coding most pathological reports. Using a web 
application developed by the CCP, each committee member reviewed the concepts of 
the subset to identify those that were most frequently used in their pathology 
departments. For each chosen concept, they also selected the description that they 
believed was most suitable. Figure 1 details the process to create provisional and 
theoretical subset and microglossary. 
2.2. Identification of concepts not included in the SNOMED CT terminology 
Spain became a member of SNOMED International in 2009, and since then, all the 
hospitals in Spain have had access to SNOMED CT terminology. From that year until 
release of the English edition of SNOMED CT in January 2017, the CCP systematically 
cross-referenced different international classifications of diseases with the successive 
versions of SNOMED CT to identify the concepts that were not yet included in this 
terminology. The classifications mapped were: the International Classification of 
Diseases for Oncology, 2nd and 3rd editions (ICD-O-2, ICD-O-3) [24,25]; the WHO/IARC 
Classification of Tumors series [26-42]; the TNM Classification of Malignant Tumors, 7th 
edition [43]; and the BANFF classification for post-transplant grades of rejection [44-47]. 
Revisions of the ICD-O morphology are closely coordinated with SNOMED CT sections 
M-8 and M-9 (SnomedIDs), and ICD-O codes and names are the same as the 
corresponding concepts in SNOMED CT. Following the recommendations of the 
pathologists participating in the study, we also reviewed the molecular and genetic 
procedures of the Hospital Clínic of Barcelona for hematological neoplasms and the 
classification for neuromuscular pathology of the neuropathology research group of 
Bellvitge Biomedical Research Institute (Figure 1). For the concepts not included in 
SNOMED CT, the CCP assigned an axis and a parent concept from the SNOMED CT 
hierarchy. Subsequently, the Office of Standards and Interoperability (OSI) of the 
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TicSalut Foundation (a public organization established by the Catalan Ministry of Health) 
created a Catalan extension of SNOMED CT and included it in the provisional subset and 
microglossary (henceforth, theoretical subset and microglossary) (Figure 1), in line with 
the standard mechanisms of SNOMED International [48].  
Mapping and concept creation in the Catalan extension is systematically performed in 
accordance with updates of the international classifications, scientific publications, and 
upon personal requests from any pathologist. Every year, extensions are created and 
systematically incorporated into the theoretical subset and microglossary. Since 2009 up 
until 2017, we have updated the theoretical subset and microglossary in accordance 
with the annual SNOMED CT updates as follows: a) by removing from the subset the 
concepts that have become inactive and adding the substitutes proposed by SNOMED-
CT; and b) by periodically adding the concepts created in the Catalan extension.  
The OSI is responsible for distributing the SNOMED CT terminology and the theoretical 
subset and microglossary along with the implementation guides to all centers. To 
streamline the coding of pathology reports, the OSI recommends implementing 
hierarchical search engines into the computer applications of laboratories. The 
computer software searches for the concepts first in the microglossary; if the concepts 
are not there, it searches in the subset and lastly, if they are not in the subset, in the 
remaining concepts in the SNOMED CT terminology. 
2.3. Implementation of Catalan Pathology Registry (CPR) 
The Catalan electronic health record (CEHR) compiles the documents with structured 
data and relevant information on the evolution of patients throughout their care 
pathway in the public healthcare network [49]. Today, this platform holds the health 
records for all citizens of Catalonia and it is estimated that an average of 2 million health 
records are sent monthly from 99% of the public healthcare centers [50]. 
Each center sends EPRs to the CEHR daily using the international standard for clinical 
information exchange, the Clinical Document Architecture Release 2 (CDA R2) of Health 
Level 7 International [51]. The Catalan SNOMED CT commission agreed on the structure 
of the EPR, which mainly includes patient information from the centers that generate 
the sample (requesting center) and perform the pathological diagnosis (processing 
center), the date of receipt of the sample in the laboratory and the signature of the 
report and, finally, the topography and the diagnoses coded in SNOMED CT (Table 1). 
  
10 
 
Each topography is related at least to one diagnosis and coded with one or more 
concepts of any SNOMED CT axis except topography itself. 
 
Table 1. Required information on the electronic pathology reports included in the defined CDA R2  
of the Catalan Electronic Health Record 
 
Patient 
 CIP
1
 
 Type of ID (national identity card or passport) 
 ID number 
 First name 
 Surname(s) 
 Birth date 
 Sex 
 Postal code and district of residence 
 Nº healthcare center that prepared the report 
 Nº healthcare center that requested the report 
Pathology report 
 Report ID 
 Type of diagnostic test 
 Date of signature on diagnostic report 
 Code for department responsible for report 
 Date of entry in pathology service 
 ID of healthcare center that prepared the report (reporting center) 
 Code for department requesting the report 
 ID healthcare center that requested the report (requesting center) 
Pathologist 
 Name of pathologist signing the pathology report 
 National identity card number of the pathologist  
 First name  
 Surname(s) 
Sample2 
 ID biological sample  
 Topographic code (ConceptID of the SNOMED CT classification) 
 Description of topographic code  
 Result code (ConceptID of the classification SNOMED CT) 
 Description of result code 
1
Personal Identification code of the health card of Catalan residents; 2Each topography is related at least to one 
diagnosis, coded with one or more concepts of any SNOMED CT axis except topography. 
 
A number of validation checks have been implemented to ensure the integrity and 
quality of the EPR data sent to CEHR. EPRs that do not pass the validations are 
automatically returned to the centers to report the error. Once corrected and validated, 
the EPR is again forwarded for entry in the CEHR (Figure 2). The CPR contains 1.17 
million samples from 68 hospitals and 96 primary care centers, and the CCP is currently 
validating the integrity and quality of CPR information. This article describes some of 
these validations, specifically defining pathologists’ actual use of the SNOMED CT 
concepts compared to the concepts included in the theoretical subset and 
microglossary, with the aim of refining them for alignment with professional practice. 
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2.4. Validation of the theoretical subset and microglossary: comparison of the 
concepts included in the theoretical subset and microglosary with the concepts of 
SNOMED CT used by pathologists 
The theoretical subset and microglossary were validated by comparing the concepts 
included therein with the SNOMED CT concepts used to code more than a million 
samples over more than two years (January 1, 2015 - May 31, 2017). After this 
comparison, the theoretical subset and microglossary were adapted to reflect the actual 
coding performed by the pathologists, resulting in the final subset and microglossary. 
The comprehensive analysis was carried out by: geographical area of patient’s 
residence, type of care (primary/hospital), hospital level, medical-surgical specialty 
generating the sample, and the SNOMED CT axes to which the concepts pertain. 
The final subset included all the SNOMED CT concepts that were likely to be used in a 
pathology laboratory, regardless of their frequency of use. Hence, the following 
concepts were included: (a) those in the theoretical subset, (b) those in the Catalan 
extension, and finally, (c) those used by pathologists that were not initially included in 
the theoretical subset. The final microglossary was adapted to include only the concepts 
from the final subset most frequently used according to the following method: (a) those 
used at least 20 times in the study period, and (b) regardless of their frequency of use, 
the concepts of the Catalan extension originating from the ICD-O classifications, 
WHO/IARC Classification of Tumors, TNM 7th Edition, and personal requests from 
pathologists. The final subset and microglossary were delivered to the OSI for 
distribution to all pathology laboratories in public healthcare centers of Catalonia 
(Figure 2). 
We performed all statistical analyses with the R statistical package, with the 
libraries'tableone' for the descriptive analysis and 'rgdal', 'cartography', 'rgeos', and 
'dplyr' for mapping [52]. The geographic information, in geopackage format (gpkg), was 
downloaded from the InstaMaps application of the Cartography Institute of Catalonia 
[53]. 
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3. Results 
 
3.1. Definition of the pathology subset and microglossary from the College of 
American Pathologists (CAP) subset 
We removed 55,555 concepts from the CAP subset: 4,402 that were inactive and 51,153 
that were not strictly related to pathology, leaving a total of 16,397 remaining concepts. 
Following review from the pathologists, the microglossary was whittled down to 4,230 
concepts (Figure 1). Table 2 shows the distribution of the active concepts in the CAP 
subset and of the provisional subset and microglossary according to the axes of the 
current SNOMED CT. Of the concepts in the provisional subset and microglossary, 88.9% 
and 90.9% belong, respectively, to the body structure and clinical findings, while in the 
CAP subset, 61.3% of the concepts belong to these two axes. 
 
Table 2. Number of concepts included in the subset and microglossary of Catalonia from the CAP’s 
Pathology Subset in 2006. 
  
CAP’s Pathology subset1 (2006) 
Provisional 
subset2 
Provisional 
microglossary 
Axes N %  N % N % 
Body structure  28,988 40.3  10,267 62.6 2,542 60.1 
Clinical finding  15,093 21.0  4,314 26.3 1,301 30.8 
Environment  15 0.0  -  -  
Event  143 0.2  39 0.2 5 0.1 
Metadata 165 0.2  10 0.1 6 0.1 
Observable 
entity  1,077 1.5 
 
38 0.2 4 0.1 
Organism  662 0.9  101 0.6 72 1.7 
Product  142 0.2  2 0.0 1 0.0 
Physical force  42 0.1  -  -  
Physical object  431 0.6  56 0.3 2 0.0 
Procedure  11,259 15.6  803 4.9 128 3.0 
Qualifier value  956 1.3  77 0.5 15 0.4 
Record artifact  69 0.1  2 0,0 1 0.0 
Situation  54 0.1  9 0.1 4 0.1 
Social context  11 0.0  6 0.0 1 0.0 
Special concept  125 0.2  19 0.1 6 0.1 
Specimen  1,027 1.4  428 2.6 107 2.5 
Staging  1,041 1.4  3 0.0 -  
Substance  4,863 6,8  223 1.4 35 0.8 
Null3 5,789 8.0  -  -  
Total4 71,952 100.0  16,397 100.0 4,230 100.0 
 
1Pathology subset of College of American Pathologists (CAP) of the year 2006, an updated and expanded 
version of the old microglossary for surgical pathology. 2The CAP Pathology subset for 2006, after revision by 
the Catalan Cancer Plan and the Catala SNOMED CT Commission. 3No axis has been defined because the 
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concepts in the January 2017 release of SNOMED CT are inactive. 4Concepts of the provisional subset and 
microglossary represent 22.8% and 5.9%, respectively, from the initial CAP’s pathology subset. 
3.2. Identification of concepts not included in the SNOMED CT terminology 
The systematic mapping of SNOMED CT with TNM, BANFF and WHO/IARC international 
classifications identified 252 concepts not included in this terminology. Two high-
technology hospitals identified 374 concepts: 108 pertaining to neuromuscular 
pathology and 266 related to genetic and molecular diagnostic procedures. Some 
pathologists requested concepts not included in SNOMED CT (n = 334). One request was 
to include “in situ” as well as metastatic behavior for some tumors previously coded 
only as invasive. This process was performed for some tumors with SnomedIDs starting 
with M-8 or M-9 (n = 808). The concepts created for the Catalan extension of SNOMED 
CT (n = 1,576) are shown in Table 3 according to the source of the information and, in 
Table 4, according to the axes of SNOMED CT where they were assigned. 
Table 3. Catalan extension according the information source used to identify concepts not included in 
SNOMED CT. 
 
Bibliographic 
references 
 
Identification: source of the concepts not included in SNOMED CT* Concepts 
N % 
    
[43] TNM Classification of Malignant Tumours, 7th edition  66 4.2 
[44-47] BANFF classification of rejection 64 4.1 
Own compilation1 Neuromuscular pathology  108 6.9 
[26-42] WHO/IARC Classification of Tumors  122 7.7 
Own compilation2 Molecular & genetic procedures 266 16.9 
Own compilation Personal requests from pathologists 334 21.2 
Automatically 
created 
In situ/metastatic behaviour of invasive tumours in SNOMED CT (M-8 & 9) 
616 39.1 
 Total 1,576 100.0 
*Systematic mapping up to January 2017 release of SNOMED CT International; 
1
Bellvitge Neuropathology Research 
Group; 2Hospital Clínic of Barcelona 
 
Table 4. Concepts of the Catalan extension according to the axes of SNOMED CT where they were 
assigned. 
 
Axes N % 
Body structure  897 56.9 
Clinical finding  497 31.5 
Environment  -  
Event  -  
Metadata -  
Observable entity  10 0.6 
Organism  2 0.1 
Product  -  
Physical force  -  
Physical object  -  
Procedure  124 7.9 
Qualifier value  6 0.4 
Record artifact  -  
Situation  -  
Social context  1 0.1 
Special concept  5 0.3 
Specimen  32 2.0 
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Staging  -  
Substance  2 0.1 
Total 1,576 100.0 
The provisional subset and microglossary increased to 17,973 and 5,806 concepts, 
respectively, following inclusion of the concepts from the Catalan extension; together, 
these concepts constituted the theoretical subset and microglossary. 
3.3. Implementation of Catalan Pathology Registry (CPR) 
From January 1, 2015 to May 31, 2017, 1,052,860 EPRs were collected in the CPR, 
corresponding to 734,666 patients and 1,173,433 samples from 164 health centers (96 
primary care, 68 hospitals). The centers supplying the samples are located throughout 
Catalonia in both rural and urban areas; hospitals include both general hospitals and 
high-technology reference centers. Figure 3 shows the distribution of the Catalan 
population and the number of samples recorded in the CPR according to their 
geographical area. The dark blue areas correspond to densely populated urban areas 
with more high-technology centers and pathology laboratories and, therefore, the 
largest concentration of samples. On the contrary, the light blue color represents more 
sparsely populated rural areas with fewer high-technology hospitals that supply fewer 
samples.  
Reference and/or high-technology hospitals supplied 79.6% of the samples, of which 
over two-thirds correspond to the female genital tract (42.5%), the digestive system 
(21.8%), skin (9.3%), and urinary system (7.8%). In general, this pattern is similar to that 
of general hospitals, although the percentage of samples from the digestive tract 
dominates there (29.3%, 33.4%, 12.3%, and 8.0%, respectively). The samples from the 
primary care centers, where 5% of all samples from Catalonia are generated, come 
mainly from the female genital system (82.9%) (Table 5). Overall, 42.5% (n = 498,704) of 
the samples collected in the CPR correspond to the female genital tract, and of these, 
77.3% come specifically from the external female genitalia (cervix, vagina and vulva). 
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Table 5. Number of samples according to type of healthcare center and speciality 
 
1Small or geographically isolated hospitals in which few specialties are treated or basic hospitals that cover the usual 
health requirements of the population; 2Reference hospitals in which practically all health problems can be treated, 
plus high-technology hospitals that treat specific illnesses requiring the use of specialized equipment/procedures; 
3Including: otorhinolaryngology, maxillofacial surgery, and odontology; 4Including samples from lymph nodes, adipose 
tissue, multiple topographic sites, chest, back, axillary region, and necropsies. 
 
3.4. Validation of the theoretical subset and microglossary for pathology: comparison 
of the concepts included in the theoretical subset and microglosary with the concepts 
of SNOMED CT used by pathologists 
During the study period, pathologists used 6,482 concepts (2.0%) of the 328,308 
concepts included in SNOMED CT (n = 326,732) and the Catalan extension (n = 1,576). Of 
the concepts used, 95.9% belong to four axes of SNOMED CT: body structure (45.4%), 
clinical finding (42.3%), procedure (5.0%), and specimen (3.2%) (Table 6). 
If we compare the theoretical dictionaries with the 6,482 concepts used by pathologists, 
we note that 5,073 concepts were already included in the theoretical subset (78.3%) and 
3,668 in the theoretical microglossary (56.6%). The concepts used and included in the 
theoretical subset and microglossary come mostly from the body structure (subset: 
52.4%; microglossary: 57.0%) and clinical finding axes (36.8% and 32.5%, respectively). 
The concepts used but not included in the theoretical subset and microglossary 
correspond mainly to the clinical finding axis (62.0% and 55.0%, respectively), followed 
at some distance by those of the body structure axis (20.1% and 30.2%), procedure axis 
(7.7% and 6.5%), and specimen axis (3.3% and 3.2%) (Table 6). 
 
Medical or surgical specialty 
 
Primary  
care 
 
N = 96 
General  
hospital1 
 
N = 36 
Reference & 
high-technology 
hospitals2 
N = 22 & 10 
 
Total 
 
N = 164 
         
 N % N % N % N % 
Breast pathology   667 1.1   6,736  3.7 32,495 3.5 39,898 3.4 
Cardiology & cardiovascular surgery 1 0.0    166  0.1   2,786  0.3 2,953 0.3 
Dermatology 2,814 4.8 22,316  12.3 87,190 9.3 112,320 9.6 
Endocrinology 28 0.0    472 0.3   2,318 0.2 2,818 0.2 
Gastroenterology & digestive surgery 3,86 5.2 60,504 33.4 203,225 21.8 266,815 22.7 
Gynecology & obstetrics 48,715 82.9 52,993 29.3 396,996 42.5 498,704 42.5 
Head & neck surgery3 140 0.2 3,743 2.1 22,259 2.4 26,142 2.2 
Hematology 0 0.0 298 0.2 8,461 0.9 8,759 0.7 
Nephrology & urology 2,821 4.8 14,564 8,0 72,960 7.8 90,345 7.7 
Neurology & neurological surgery 1 0.0    434 0.2 6,353 0.7 6,788 0.6 
Ophthalmology 14 0.0    384 0.2 1,909 0.2 2,307 0.2 
Pneumology & thoracic surgery   141 0.2 6,114 3.4 37,831 4,1 44,086 3.8 
Traumatology & rehabilitation   174 0.3 6,295 3.5 21,838 2.3 28,307 2.4 
Unclassifiable4 189 0.3 6,104 3.4 36,898 4.0 43,191 3.7 
Total 58,791 5.0 181,123 15.4 933,519 79.6 1,173,433 100.0 
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The final subset grew by 1,409 concepts compared to the theoretical subset, after 
adding all the concepts of SNOMED CT that were used but not initially included (19,382 
versus 17,973 concepts in the theoretical subset). In contrast, the theoretical 
microglossary shrunk by 56.9%, from 5,806 concepts to 2,502. Of the concepts included 
in the final microglossary, 560 pertain to the Catalan extension (Table 7). Finally, after 
adapting the theoretical subset and microglossary to pathologists’ actual use of 
SNOMED CT and the Catalan extension, the final subset and microglossary include 5.9% 
and 0.8%, respectively, of the SNOMED CT concepts.  
 
Table 6. Concepts used by pathologists according to the SNOMED CT axes and belonging to the 
theoretical subset and microglossary 
      
  Catalan Pathology Registry (CPR) 
 
 
     
SNOMED CT (January  
2017) + Catalan extension 
 
Concepts 
used by 
pathologists 
 Theoretical subset   Theoretical microglossary  
  
 
   Included Not included  Included Not included 
Axes  N 
 
N %  N % N %  N % N % 
  
 
            
Body structure 32,427 
 
2,941 45.4  2,658 52.4 283 20.1  2,092 57.0 849 30.2 
Finding 107,963 
 
2,740 42.3  1,867 36.8 873 62.0  1,191 32.5 1,549 55.0 
Environment 1,821 
 
-   -  -   -  -  
Event 3,621 
 
6 0.1  6 0.1 -   2 0.1 4 0.1 
Metadata 1,590 
 
12 0.2  7 0.1 5 0.4  6 0.2 6 0.2 
Observable entity 8,836 
 
34 0.5  22 0.4 12 0.9  14 0.4 20 0.7 
Organism 33,965 
 
71 1.1  61 1.2 10 0.7  53 1.4 18 0.6 
Product 17,401 
 
2 0.0  1 0.0 1 0.1  1 0.0 1 0.0 
Physical force 171 
 
-   -  -   -  -  
Physical object 15,107 
 
8 0.1  5 0.1 3 0.2  2 0.1 6 0.2 
Procedure 56,490 
 
322 5.0  213 4.2 109 7.7  139 3.8 183 6.5 
Qualifier value 9,476 
 
53 0.8  24 0.5 29 2.1  13 0.4 40 1.4 
Record artifact 284 
 
1 0.0  1 0.0 0 0.0  1 0.0 -  
Situation  4,431 
 
8 0.1  3 0.1 5 0.4  3 0.1 5 0.2 
Social context 4,747 
 
1 0.0  1 0.0 -   1 0.0 -  
Special concept 655 
 
10 0.2  8 0.2 2 0.1  6 0.2 4 0.1 
Specimen 1,669 
 
205 3.2  158 3.1 47 3.3  114 3.1 91 3.2 
Staging  1,500 
 
5 0.1  1 0.0 4 0.3  -  5 0.2 
Substance 26,154 
 
63 1.0  37 0.7 26 1.8  30 0.8 33 1.2 
Total 1 328,308  6,482 2.0           
Total in CPR 2   6,482    5,073  78.3 1,409 21.7  3,668 56.6 2,814 43.4 
 
1Percentage calculated based on total: 328,308. 2Percentage calculated based on total in CPR: 6,482.  
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Table 7. Concepts included in the final subset and microglossary according to the SNOMED CT 
axes.  
 
  Subset Microglossary 
Axes N % N % 
Body structure  11,447 59.1 1,364 54.5 
Clinical finding  5,684 29.3 777 31.1 
Environment  -  -  
Event  39 0.2 -  
Metadata 15 0.1 5 0.2 
Observable entity  60 0.3 13 0.5 
Organism  113 0.6 28 1.1 
Product 3 0.0 1 0.0 
Physical force  -  -  
Physical object  59 0.3 2 0.1 
Procedure  1,036 5.3 174 7.0 
Qualifier value  112 0.6 12 0.5 
Record artifact  2 0.0 -  
Situation  14 0.1 1 0.0 
Social context  7 0.0 1 0.0 
Special concept  26 0.1 1 0.0 
Specimen  507 2.6 107 4.3 
Staging and scales 7 0.0 -  
Substance  251 1.3 16 0.6 
Total 19,382 100.0 2,5021 100.0 
 
1 Concepts from the final microglossarly included in the final pathology subset for Catalonia represent 12.9% 
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4. Discussion 
To our knowledge, this is the first population-level study that analyzes the SNOMED CT 
concepts used for coding 1.17 million pathology samples. Of the 328,308 concepts 
available for coding the diagnoses (326,732 from SNOMED CT and 1,576 from the 
Catalan extension), only 2% have been used, evidencing the inherent scope and 
complexity of this terminology. Unlike the ICD [8,9] and ICD-O classifications [24,25]—
both widely used globally to code diagnoses recorded on hospital discharge reports, 
mortality records and cancer registries—SNOMED CT is not backed by standard norms 
of use [12,54]. The scope of concepts ordered in hierarchies and axes, together with the 
lack of rules of use, complicates the functionality of SNOMED CT for coding, extracting, 
consulting, and analyzing the data. Defining different subgroups of SNOMED CT by 
discipline or field could increase its functionality. The challenge lies in how to choose the 
concepts to be included in a given subset from a total of over 300,000. 
In order to facilitate the use of SNOMED CT among pathologists, we initiated the 
implementation of the CPR by first defining the theoretical subset and microglossary for 
pathology.  CPR has also allowed us to refine our theoretical subset and microglossary in 
line with how pathologists actually use the clinical terminology, ensuring their 
functionality. The final microglossary only included the SNOMED CT concepts that were 
used more than 20 times during the study period. Those used fewer than 20 times were 
excluded from the final microglossary. As a result, the final microglossary was shorter 
than the theoretical microglossary. However, any concepts used by the pathologists 
(regardless of how many times) that were not included in the theoretical subset were 
included in the final subset. This is why the final subset was larger than the theoretical 
subset. 
At the time of defining a pathology subset, some authors had already questioned 
whether the morphological concepts should not be based mainly on those included in 
the body structure axis or—when they are not available there—the clinical findings axis, 
or even whether the two should be initially combined [12]. Our experience is that 
combining both axes enables coding most of the morphologies diagnosed by 
pathologists. Indeed, 17,131 of the 19,382 concepts (88.4%) of the final subset belong to 
these two axes (body structure: 59.1%; clinical finding: 29.3%). The final microglossary 
follows a very similar pattern, with 2,141 of the 2,502 concepts (85.6%) corresponding 
to the two axes (body structure, 54.5%; clinical findings, 31.1%). The body structure axis 
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of SNOMED CT contains a subhierarchy itself due to morphology that includes specific 
concepts for neoplasms. The SnomedIDs of these concepts (M-8, M-9) coincide with the 
morphological codes published in the ICD-O-3 and the WHO/IARC Classification of 
Tumors series [26-42], and are, respectively, the referents to morphologically classify 
the neoplasms in cancer registries and among pathologists. This is probably why coding 
of morphological diagnoses of neoplasms is the most homogeneous among 
pathologists. For non-neoplastic pathologies, which lack the traditional norms for coding 
that exist for neoplasms, there is more dispersion in the use of concepts. In addition, 
some nosological entities may require more than one morphological concept to properly 
define the diagnosis. For example, celiac disease has a specific concept that defines it in 
the clinical finding axis (ConceptID: 396331005), but it probably requires three concepts 
to be defined properly: villous atrophy (ConceptID: 75581001), crypt hyperplasia 
(ConceptID: 52688008 + 76197007) and lymphocyte infiltration (ConceptID: 
445925008). Therefore, to adequately catalog some non-neoplastic diseases and to 
facilitate the search and analysis of data, using more clinical concepts that encompass 
more than one morphological feature might offer more functionality to the pathologist. 
The current SNOMED CT format introduced in 2011, Release Format 2 (RF2), differs from 
the previous format (RF1) in that it does not maintain the SnomedID [54], which is  
equivalent to the code for cataloging the morphological entities of the ICD-O-3 and the 
WHO/IARC classifications and which the pathologists used to code with SNOMED II. The 
OSI, in anticipation of this change, recommended to all centers in Catalonia that the 
computer applications of the pathology laboratories migrating to SNOMED CT take into 
account that the ConceptID was the concept identifier and the DescriptionID was the 
description identifier. In general, the applications show the descriptions offered by 
SNOMED CT for the term requested, and the pathologist has to choose the most 
suitable. When pathologists perform coding based on a choice of descriptions, they 
cannot reference the associated SnomedID that they had used previously. For this 
reason, we defined a pathology-specific subset and microglossary in Catalonia to make 
the coding process faster and easier for pathologists. Incorporating them alongside 
SNOMED CT in the computer software of pathology laboratories has made it possible to 
delimit the concepts that are specific to pathology (subset) and the most frequently 
used of these concepts (microglossary).    
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SNOMED CT does not cover pathologists’ every daily need, as the clinical reality is 
dynamic and changing. Several authors have also described a gap in the genetic and 
molecular procedures and diagnoses of SNOMED CT [14]. We have constated that 
SNOMED CT incorporates the new morphological entities proposed in the WHO/IARC 
Classification of Tumors series [26-42] and in the TNM Classification of Malignant 
Tumors [43], albeit after some delay with respect to its date of publication. To adapt 
SNOMED CT to local needs in a flexible and standardized way, the possibility exists to 
create local extensions. The concepts included in the Catalan extension were made 
available to the pathologists in accordance with their requirements (Table 3), but only 
30.1% of these concepts have been used. The relatively low use of the Catalan extension 
is probably due to the use of generic codes when coding some morphological diagnoses 
and the scarce coding of the additional detailed information contained in the pathology 
reports (TNM, degree of differentiation, molecular and genetic characteristics, etc.). 
However, Catalan extension has been a fast and functional way to incorporate new 
concepts not yet included in SNOMEDT CT. It is also important to emphasize that local 
requirements should be tendered to the international body (SNOMED International) to 
evaluate their relevance to international versions. 
Readers should take into account some limitations when interpreting this project. First 
of all, in general, the SNOMED CT concepts used to code are generic in relation to the 
detailed descriptions contained in the pathology reports. In any case, in our experience, 
the use of generic concepts has not varied significantly during the migration from 
SNOMED II to SNOMED CT. The fact that the SNOMED CT terminology is more extensive 
than SNOMED II could explain in part its scarce use. Coding accuracy will likely improve 
as pathologists continue to use SNOMED CT. We believe the use of generic concepts has 
no significant effect on the final subset, as this final subset included all SNOMED CT 
concepts related to pathology, regardless of their frequency of use.  However, the use of 
generic concepts may have affected the final microglossary, as it includes only the 
concepts most frequently used by pathologists. More precise coding would almost 
certainly have generated a larger final microglossary. This limitation is difficult to 
overcome unless we extract the information from the natural language of the pathology 
reports, as indeed several countries are doing with good results [15,17,55]. Secondly, 
pathology is important in two methodological areas of the PBCRs: a) the identification of 
possible neoplasms and b) the morphological description of the neoplasm ultimately 
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included in the registry. Imprecise coding affects the detailed description of neoplasm 
morphology but not the description of tumor behavior, which means neoplasms will 
always be correctly identified. However, to improve the quality of the information in the 
PBCRs, for the time being it is necessary to systematically consult the electronic 
pathology records available in the CEHR. Third, the information that is not strictly 
related to topography and morphological diagnosis, such as the staging or biomolecular 
markers, is often not coded. Therefore, in the final microglossary the concepts intended 
to code these aspects may be under-represented. Processing the natural language of 
the electronic pathology reports could, not only improve the accuracy of morphology 
coding, but also increase the coding of the additional information contained in the 
pathology reports [15,56-57]. Fourth, another limitation to keep in mind is the 
topographic origin of the samples. Pathological diagnoses depend to a great extent on 
the topography of the samples. In our case, gynecological samples were the most 
frequent, followed by those originating in the digestive system, skin, and urinary system, 
which together account for almost three quarters of the topographies recorded in the 
CPR. It is possible that concepts related to relatively rare topographies are less likely to 
be included in the microglossary than those from the most frequent topographies. 
Finally, in Catalonia, hematology-cytology laboratories are not usually integrated into 
pathology laboratories, and this probably has a negative impact on the level of detail 
used when evaluating these pathologies compared to other clinico-pathological entities. 
The CPR database currently includes 1.17 million samples from all the pathology 
laboratories of the public healthcare centers in Catalonia. The population coverage of 
this registry constitutes one of the principal strengths of this study, since the final subset 
and microglossary were defined without any risk of bias associated with the 
geographical area; the healthcare setting (primary or hospital); the level of complexity of 
the centers, and the clinical departments generating the samples; or the representation 
of pathologists (439 pathologists coded samples). Another advantage of this study is the 
effort made to identify neoplastic and non-neoplastic concepts not included in SNOMED 
CT. The Catalan extension of SNOMED CT, as well as the final subset and microglosary, 
can be downloaded from the OSI website: 
http://www.ticsalut.cat/estandards/terminologia/obtencio-apat/. The final subset and 
microglossary will be subject to a process of continuous improvement, as they will 
undergo periodic evaluation and adaptations based on the actual use of SNOMED CT. 
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Future updates will also take into account publication of the international versions of 
SNOMED CT, the equivalence with concepts created in the Catalan extension, and 
requests coming directly from pathologists. The CPR therefore requires substantial 
maintenance to ensure the continued functionality of SNOMED CT for pathologists. 
Traditionally, pathology diagnoses have been a prime source of information for 
detecting cancer cases in PBCRs and for evaluating cancer screening programs. The 
availability of the CPR in Catalonia opens the door to the creation of other population-
based disease registries and to the amplification of information from existing registries.   
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Sentences to add to a forthcoming JBI special issue on ontology quality assurance.    
 
The systematic crossing of SNOMED CT with various international classifications of 
pathological entities and the creation of new concepts requested by pathologists, has 
allowed the updating and adaptation of the terminology according to the requirements 
of SNOMED CT users.   
 
These subsets (19,382 and 2,502 concepts respectively) allow pathologists to search and 
select concepts more efficiently than by examining the whole SNOMED-CT terminology 
data base as the later will only be performed in the few cases when the restricted search 
fails. 
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GRAPHICAL ABSTRACT: Flow of the electronic pathology records from the public health centers 
to the Catalan Pathology Registry. Definition/maintenance of the subset & microglossary of 
pathology and the Catalan extension of SNOMED CT. 
Foot-note on GRAPHICAL ABSTRACT: 
EPR: Electronic Pathology Records; CDA: Clinical Document Architecture; CEHR: Catalan 
Electronic Health Record.   
 
Figure 1. Definition of the theoretical subset and microglossary for pathology. 
Foot-note on Figure 1:  
SOURCES OF INFORMATION: 
1
TNM classification of malignant tumours, 7th edition; 
2International Classification of Diseases for Oncology, 2nd and 3rd editions; 3WHO/IARC 
Classification of tumours; 4Banff schema for grading allograft rejection; 5Molecular and genetic 
procedures provided by Hospital Clínic; 6Neuromuscular pathology classification provided by 
Bellvitge Hospital; 
7
Personal requests from pathologists. 
 
Figure 2. Flow of the electronic pathology records from the public health centers to the Catalan 
Pathology Registry. 
 
Figure 3. Catalan population and number of biological samples according to geographical area 
Foot-note on Figure 3: 
 EPR: Electronic Pathology Records; CDA: Clinical Document Architecture; CEHR: Catalan 
Electronic Health Record.  
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Highlights 
 
• We propose a functional subset and microglossary of pathology from SNOMED CT 
• Encoding more than 1 million samples, defined the use of SNOMED CT in pathology 
 1,576 new concepts were added to SNOMED CT as an extension 
 Pathology's subset and microglossary will be continuously improved and validated 
 
